KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Equity Ratio (2018 - 2026)

Twist Bioscience has reported Equity Ratio over the past 9 years, most recently at 0.67 for Q1 2026.

  • Quarterly Equity Ratio fell 8.92% to 0.67 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.67 through Mar 2026, down 8.92% year-over-year, with the annual reading at 0.74 for FY2025, 4.24% down from the prior year.
  • Equity Ratio was 0.67 for Q1 2026 at Twist Bioscience, down from 0.71 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.85 in Q1 2022 and troughed at 0.67 in Q1 2026.
  • The 5-year median for Equity Ratio is 0.8 (2024), against an average of 0.78.
  • Year-over-year, Equity Ratio rose 2.97% in 2022 and then fell 8.92% in 2026.
  • A 5-year view of Equity Ratio shows it stood at 0.82 in 2022, then dropped by 1.83% to 0.81 in 2023, then dropped by 6.95% to 0.75 in 2024, then fell by 4.59% to 0.71 in 2025, then decreased by 5.85% to 0.67 in 2026.
  • Per Business Quant, the three most recent readings for TWST's Equity Ratio are 0.67 (Q1 2026), 0.71 (Q4 2025), and 0.74 (Q3 2025).